A team of London scientists have taken a major step in making the use of artificial veins and arteries in coronary bypass grafts a reality. In a study published in the June 2008 print issue of The FASEB Journal, researchers describe how they developed this artificial graft tissue by combining man-made materials with human cells to make it elastic and durable and so it can attach to host tissue.
"Obviously this advance could be a medical breakthrough that saves millions of lives around the world," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal, "but even more tantalizing is the successful fusing of living cells to nonliving substances that actually—heal—by forming a stronger bond to each other and to host tissue once put in use. This might even be called a start toward 'cyborg engineering.'"
In the research report, scientists describe how they took an elastic scaffold (the material that gives the artificial graft its shape) of compliant poly(carbonate-urea)urethane and incorporated human vascular smooth muscle cells and epithelial cells from umbilical cords. Then they took the artificial grafts and simulated blood flow in the laboratory to test their durability. They found that as the pulsing fluid flow slowly increased, the artificial graft's performance actually improved. The researchers hypothesize that this improvement is because the movement of fluid through the graft stimulates the smooth muscle and epithelial cells to release proteins that strengthen their ability to attachment to the elastic scaffold and other tissues.
"The notion that any body part could be engineered in a lab, attach to existing tissue 'naturally,' and grow stronger as it is being used is something thought completely impossible just 20 years ago," Weissmann added. "It is only a matter of time before human tissues can be engineered to be at least as good as the originals, and this study moves us toward that reality."
According to the National Institutes of Health, coronary artery bypass grafting is the most common open heart surgery in the United States, with 500,000 procedures performed each year. It is one of only a few surgical options to treat coronary artery disease, which is the leading cause of death in the United States. During this surgery, a healthy vein or artery from another part of the body is connected to the blocked coronary artery to route blood flow around a blocked passage.
Current procedures are limited, however, by the availability of healthy veins or arteries as well as the patient's ability to survive both aspects of the procedure. Furthermore, many patients experience significant pain in the area where the vein or artery was removed. Using artificial veins or arteries instead would reduce recovery time, reduce pain, and save lives by making this type of surgery more available to people who need it.
Source: Federation of American Societies for Experimental Biology
Related stories:
Medical Textiles No Longer for 'External Use Only'
If you’ve ever had a broken arm – or a paper cut – you probably appreciated the healing role textiles played in your recovery. New types of materials are now being used to treat internal illnesses and injuries, making surgeries less invasive, for example, and delivering drugs with greater efficiency.
Nanotextured implant materials: blending in, not fighting back
Biomedical engineers are constantly coming up with ways to repair the human body, replacing defective and worn out parts with plastic, titanium, and ceramic substitutes – but the body does not always accept such substitutes seamlessly. Engineers from Brown and Purdue universities have found that simply changing the surface texture of implants can dramatically change the way cells colonize a wide variety of materials.
Artificial Nanoscale Cholesterol Carrier Targets Brain Tumors
Low-density lipoprotein, better known as LDL, is one of the chief villains involved in the development of coronary artery disease. But new research results suggest that for cancer patients with glioblastoma multiforme (GBM), the most common malignant brain tumor in adults, synthetic LDL-like nanoparticles could prove to be the vehicle of choice for delivering potent anticancer drugs to tumor cells while sparing healthy neighboring cells.
Circulatory system on a chip lets scientists mimic heartbeat
A tiny chip that mimics a circulatory system—right down to the rhythm of a human heart beat—could be an invaluable tool in understanding the causes of cardiovascular disease and developing drug therapies.
The system of tiny valves and channels on the chip mimic blood flow in the body, said biomedical engineering professor Shuichi Takayama, corresponding author of the paper, "Computer Controlled Microcirculatory Support System for Endothelial Cell Culture and Shearing," scheduled to appear in July in the journal Analytical Chemistry.
'Nano-bumps' could help repair clogged blood vessels
Biomedical engineers at Purdue University have shown that "vascular stents" used to repair arteries might perform better if their surfaces contained "nano-bumps" that mimic tiny features found in living tissues.
The researchers already have shown in a series of experiments that bone and cartilage cells in petri dishes attach better to materials that possess smaller surface bumps than are found on conventional materials used to make artificial joints. The smaller features also stimulate the growth of more new bone tissue, which is critical for the proper attachment of artificial joints once they are implanted.
Landmark study unlocks stem cell, DNA secrets to speed therapies
In a groundbreaking study led by an eminent molecular biologist at Florida State University, researchers have discovered that as embryonic stem cells turn into different cell types, there are dramatic corresponding changes to the order in which DNA is replicated and reorganized.
Researchers design artificial cells that could power medical implants
Researchers at Yale University have created a blueprint for artificial cells that are more powerful and efficient than the natural cells they mimic and could one day be used to power tiny medical implants.
Using living cells as nanotechnology factories
In the tiny realm of nanotechnology, scientists have used a wide variety of materials to build atomic scale structures. But just as in the construction business, nanotechnology researchers can often be limited by the amount of raw materials. Now, Biodesign Institute at Arizona State University researcher Hao Yan has avoided these pitfalls by using cells as factories to make DNA based nanostructures inside a living cell.